Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Circulation|February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trialInder S Anand, Peter Carson, Elizabeth Galle, et al.
Plos One|July 29, 2021
Return of individual research results: What do participants prefer and expect?Sabina Sayeed, Robert Califf, Robert Green, et al.
European Journal of Heart Failure|May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trialScott D Solomon, Rudolf A de Boer, David DeMets, et al.
Journal of Biopharmaceutical Statistics|June 13, 2022
Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trialsAriadna Garcia, Vidhya Balasubramanian, Justin Lee, et al.
European Heart Journal|August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsMarco Metra, Eric Eichhorn, William T Abraham, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
Journal of the American College of Cardiology|March 26, 2025
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA TrialDavid J Maron, Jonathan D Newman, Rebecca Anthopolos, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Circulation. Heart Failure|August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER TrialAlexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.
Pageof 7